Terms: = Germ cell tumor AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1
106 results:
1. [Gonadoblastoma: Clinicopathological study and literature review of 3 cases].
Bao ML; Li X; Chen G; Li H; Chen W; Li HX
Zhonghua Nan Ke Xue; 2023 Jul; 29(7):634-638. PubMed ID: 38619412
[TBL] [Abstract] [Full Text] [Related]
2. Serum cholesterol level as a predictive biomarker for prognosis of Neuroblastoma.
Min J; Wu Y; Huang S; Li Y; Lv X; Tang R; Zhao H; Wang J
BMC Pediatr; 2024 Mar; 24(1):205. PubMed ID: 38519890
[TBL] [Abstract] [Full Text] [Related]
3. Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years' experience of a single center.
Yilmaz MT; Kahvecioglu A; Yazici G; Mohammadipour S; Kertmen N; Cifci GC; Zorlu F
J Neurooncol; 2024 Apr; 167(2):295-303. PubMed ID: 38383875
[TBL] [Abstract] [Full Text] [Related]
4. Looking through the imaging perspective: the importance of imaging necrosis in glioma diagnosis and prognostic prediction - single centre experience.
Ma H; Zeng S; Xie D; Zeng W; Huang Y; Mazu L; Zhu N; Yang Z; Chu J; Zhao J
Radiol Oncol; 2024 Mar; 58(1):23-32. PubMed ID: 38378035
[TBL] [Abstract] [Full Text] [Related]
5. Endocrine tumors of the female reproductive tract.
Asa SL; Ezzat S
Mol Cell Endocrinol; 2024 Mar; 582():112123. PubMed ID: 38135144
[TBL] [Abstract] [Full Text] [Related]
6. Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small cell Lung Cancer Brain Metastases.
Vaios EJ; Shenker RF; Hendrickson PG; Wan Z; Niedzwiecki D; Winter SF; Shih HA; Dietrich J; Wang C; Salama AKS; Clarke JM; Allen K; Sperduto P; Mullikin T; Kirkpatrick JP; Floyd SR; Reitman ZJ
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1507-1518. PubMed ID: 38097090
[TBL] [Abstract] [Full Text] [Related]
7. Clinical impact of unsuccessful subcutaneous administration of octreotide LAR instead of intramuscular administration in patients with metastatic gastroenteropancreatic neuroendocrine tumors.
Krishnan T; Safro M; Furlanetto DM; Gill S; Solar Vasconcelos JP; Stuart HC; Martineau P; Loree JM
J Neuroendocrinol; 2024 Jan; 36(1):e13360. PubMed ID: 38088132
[TBL] [Abstract] [Full Text] [Related]
8. Sertoli cell-Specific Activation of Transforming Growth Factor Beta Receptor 1 Leads to Testicular Granulosa cell tumor Formation.
Fang X; Nie L; Putluri S; Ni N; Bartholin L; Li Q
Cells; 2023 Nov; 12(23):. PubMed ID: 38067144
[TBL] [Abstract] [Full Text] [Related]
9. Eosinophil may be a predictor of immune-related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary study.
Tasaki Y; Sugiyama Y; Hamamoto S; Naiki T; Uemura T; Yokota K; Kawakita D; Nakamura M; Ogawa R; Shimura T; Mimura Y; Hotta Y; Odagiri K; Ito N; Iida M; Kimura Y; Komatsu H; Kataoka H; Takiguchi S; Morita A; Iwasaki S; Okuda K; Niimi A; Yasui T; Furukawa-Hibi Y
Cancer Med; 2023 Dec; 12(24):21666-21679. PubMed ID: 37986680
[TBL] [Abstract] [Full Text] [Related]
10. Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity.
Ronchi S; Cicchetti A; Bonora M; Ingargiola R; Camarda AM; Russo S; Imparato S; Castelnuovo P; Pasquini E; Nicolai P; Ansarin M; Del Vecchio M; Benazzo M; Orlandi E; Vischioni B
Radiother Oncol; 2024 Jan; 190():110003. PubMed ID: 37956889
[TBL] [Abstract] [Full Text] [Related]
11. Outcomes and Predictors of Morbidity after Carotid Body tumor Resection.
Zambetti BR; Blitzer DN; Nagarsheth K; Toursavadkohi S
Ann Vasc Surg; 2024 Feb; 99():442-447. PubMed ID: 37914072
[TBL] [Abstract] [Full Text] [Related]
12. Mitochondrial subtype
Li Q; Jia Y; Tang B; Yang H; Yang Q; Luo X; Pan Y
Biomarkers; 2023 Dec; 28(7):643-651. PubMed ID: 37886818
[TBL] [Abstract] [Full Text] [Related]
13. Ganglioneuromas in Childhood: Hacettepe Experience With 70 Cases.
Aydin Goker ET; Yalçın B; Karnak İ; Orhan D; Haliloglu M; Ekinci S; Oguz B; Aydin B; Kurucu N; Varan A; Kutluk T
J Pediatr Surg; 2024 Mar; 59(3):483-487. PubMed ID: 37858397
[TBL] [Abstract] [Full Text] [Related]
14. Molecular and clinicopathological implications of PRAME expression in adult glioma.
Le MK; Vuong HG; Dunn IF; Kondo T
PLoS One; 2023; 18(10):e0290542. PubMed ID: 37796789
[TBL] [Abstract] [Full Text] [Related]
15. The novel prognostic nomograms for predicting cancer-specific survival and overall survival in mixed medullary and follicular cell carcinoma: A SEER-based study.
Li Y; Guo T; Gao X; Liu J
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16337-16354. PubMed ID: 37704803
[TBL] [Abstract] [Full Text] [Related]
16. Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid tumors.
Liu Y; Mullangi S; Debono D; Chen X; Pham T; Fisch MJ; Gordon AS; Hershman DL
JCO Oncol Pract; 2023 Sep; 19(9):731-740. PubMed ID: 37384847
[TBL] [Abstract] [Full Text] [Related]
17. Quantification of capture efficiency, purity, and single-cell isolation in the recovery of circulating melanoma cells from peripheral blood by dielectrophoresis.
Chen H; Osman SY; Moose DL; Vanneste M; Anderson JL; Henry MD; Anand RK
Lab Chip; 2023 May; 23(11):2586-2600. PubMed ID: 37185977
[TBL] [Abstract] [Full Text] [Related]
18. Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.
Goddard J; Castle J; Southworth E; Fletcher A; Crosier S; Martin-Guerrero I; García-Ariza M; Navajas A; Masliah-Planchon J; Bourdeaut F; Dufour C; Ayrault O; Goschzik T; Pietsch T; Sill M; Pfister SM; Rutkowski S; Richardson S; Hill RM; Williamson D; Bailey S; Schwalbe EC; Clifford SC; Hicks D
Acta Neuropathol; 2023 May; 145(5):651-666. PubMed ID: 37014508
[TBL] [Abstract] [Full Text] [Related]
19. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
[TBL] [Abstract] [Full Text] [Related]
20. [Analysis of the difference in MGMT promoter status in gliomas and its significance in prognosis assessment].
Huang J; Ma ML; Li MX; Ren XH; Cui Y; Lin S
Zhonghua Yi Xue Za Zhi; 2023 Feb; 103(7):526-529. PubMed ID: 36800777
[TBL] [Abstract] [Full Text] [Related]
[Next]